Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
SchizophreniaCerebellar FunctionCondition
Interventions
DEVICE

Transcranial Magnetic Stimulation

The TMS will be administrated using the MagVenture Mag Pro R30 device equipped with a B-70 coil. The FDA-approved iTBS sequence will be applied: 10 bursts of three biphasic pulses at 50 Hz, repeated at 5 Hz, for 10 seconds for a total of 600 pulses, and will be repeated for three times. The total stimulation time is \~10 min per session (day). Patients will receive five sessions (days) of rTMS each week, and the total treatment will last for four weeks.

Trial Locations (1)

11004

RECRUITING

Zucker Hillside Hospital, New York

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER

NCT05389787 - Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study | Biotech Hunter | Biotech Hunter